• LAST PRICE
    11.1200
  • TODAY'S CHANGE (%)
    Trending Up0.0350 (0.3157%)
  • Bid / Lots
    10.8000/ 1
  • Ask / Lots
    12.1200/ 1
  • Open / Previous Close
    11.2000 / 11.0850
  • Day Range
    Low 11.0400
    High 11.3700
  • 52 Week Range
    Low 6.3000
    High 11.9200
  • Volume
    120,083
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 11.085
TimeVolumeFENC
09:32 ET1059811.37
09:36 ET88511.3
09:38 ET10011.25
09:41 ET30011.21
09:57 ET30011.28
09:59 ET74111.154
10:01 ET30011.255
10:06 ET10011.255
10:08 ET10011.245
10:15 ET45011.235
10:30 ET10011.23
10:32 ET116011.2
10:33 ET39011.213
10:46 ET410011.19
10:48 ET580011.18
10:57 ET10011.225
11:00 ET10011.2
11:06 ET50011.225
11:08 ET50011.21
11:09 ET160011.19
11:11 ET20011.17
11:26 ET227911.21
11:49 ET97711.2
11:54 ET10011.2
11:56 ET10011.2
11:58 ET10011.21
12:00 ET20011.21
12:03 ET10011.2
12:07 ET460011.235
12:16 ET10011.2
12:18 ET30011.22
12:20 ET10011.21
12:21 ET260011.2001
12:23 ET90011.17
12:25 ET20011.17
12:27 ET194111.24
12:30 ET60011.24
12:32 ET10011.24
12:36 ET10011.21
12:43 ET30011.2
12:45 ET10011.2
12:57 ET20011.26
01:06 ET60011.22
01:14 ET10011.21
01:15 ET20011.2
01:39 ET71011.2
02:02 ET784911.21
02:09 ET10011.21
02:13 ET10011.2
02:18 ET30011.215
02:24 ET88511.2
02:29 ET120011.18
02:40 ET90011.165
02:42 ET10011.14
02:44 ET10011.14
02:45 ET394711.115
02:54 ET20011.13
02:56 ET130011.15
02:58 ET327611.165
03:02 ET210011.175
03:03 ET10011.185
03:14 ET20011.16
03:16 ET10011.16
03:20 ET40011.13
03:21 ET20011.14
03:23 ET10011.14
03:25 ET10011.14
03:30 ET40011.17
03:38 ET20011.11
03:41 ET60011.11
03:43 ET10011.13
03:45 ET10011.11
03:48 ET141411.06
03:50 ET40011.09
03:52 ET60011.07
03:54 ET50011.075
03:56 ET180011.12
03:57 ET100011.08
03:59 ET367411.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFENC
Fennec Pharmaceuticals Inc
300.7M
-14.6x
---
United StatesVSTM
Verastem Inc
298.5M
-2.9x
---
United StatesADVM
Adverum Biotechnologies Inc
293.5M
-1.2x
---
United StatesERAS
Erasca Inc
311.2M
-2.5x
---
United StatesRAPT
RAPT Therapeutics Inc
312.5M
-2.9x
---
United StatesNBTX
Nanobiotix SA
290.9M
-3.6x
---
As of 2024-03-29

Company Information

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company, which is focused on its product candidate PEDMARK. The Company sells its product through a field force, including regional pediatric oncology specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration (FDA) approved therapy indicates to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic and solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase III clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6.

Contact Information

Headquarters
68 Tw Alexander Dr PO Box 13628RESEARCH TRIANGLE PARK, NC, United States 27709
Phone
919-636-4530
Fax
919-890-0490

Executives

Independent Chairman of the Board
Khalid Islam
Chief Executive Officer, Director
Rostislav Raykov
Chief Financial Officer
Robert Andrade
Chief Operating Officer
Adrian Haigh
Independent Director
Marco Brughera

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$300.7M
Revenue (TTM)
$13.1M
Shares Outstanding
27.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.38
EPS
$-0.76
Book Value
$-0.10
P/E Ratio
-14.6x
Price/Sales (TTM)
23.0
Price/Cash Flow (TTM)
---
Operating Margin
-130.92%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.